[111In-DTPA-D-Phe]-OCTREOTIDE SCINTIGRAPHY IN METASTATIC HORMONE-REFRACTORY PROSTATIC ADENOCARCINOMA WITH HIGH CHROMOGRANIN A

被引:0
|
作者
Villa, G.
Borzone, C. [1 ]
Sambuceti, G.
Carmignani, G. [1 ]
机构
[1] Urol Clin, Genoa, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
280
引用
收藏
页码:1537 / 1538
页数:2
相关论文
共 34 条
  • [31] A dose-escalation-study evaluating the toxicity and therapeutic efficacy of 111In-DTPA-D-Phe1-octreotide in patients with metastatic neuroendocrine tumors:: Preliminary results.
    Schipper, ML
    Gotthardt, M
    Behe, M
    Diedrich, J
    Wied, MU
    Hoeffken, H
    Gratz, S
    Schlieck, A
    Arnold, R
    Behr, TM
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 315P - 316P
  • [32] L-3-[123I]iodo-α-methyltyrosine scintigraphy in carcinoid tumors:: Correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging
    Jager, PL
    Meijer, WG
    Kema, IP
    Willemse, PHB
    Piers, DA
    de Vries, EGE
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (11) : 1793 - 1800
  • [33] Value of peptide receptor scintigraphy using 123I-vasoactive intestinal peptide and 111In-DTPA-D-Phe1-octreotide in 194 carcinoid patients:: Vienna university experience, 1993 to 1998
    Raderer, M
    Kurtaran, A
    Leimer, M
    Angelberger, P
    Niederle, B
    Vierhapper, H
    Vorbeck, F
    Hejna, MHL
    Scheithauer, W
    Pidlich, J
    Virgolini, I
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1331 - 1336
  • [34] Comparison between transversal SPECT, 3-dimensional rendering and 3-dimensional rendering plus clipping in the diagnosis of somatostatin receptor distribution in malignancies using In-111-DTPA-D-Phe(1)-octreotide scintigraphy
    Kalkner, KM
    Nilsson, S
    YlaJaaski, J
    Westlin, JE
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1997, 12 (02) : 89 - 99